Eli Lilly and Co (LLY)
760.14
-11.41
(-1.48%)
USD |
NYSE |
May 10, 16:00
760.06
-0.08
(-0.01%)
After-Hours: 19:39
Eli Lilly Total Return Level: 2220.86 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 2220.86 |
May 08, 2024 | 2230.79 |
May 07, 2024 | 2238.76 |
May 06, 2024 | 2206.84 |
May 03, 2024 | 2115.57 |
May 02, 2024 | 2175.84 |
May 01, 2024 | 2235.83 |
April 30, 2024 | 2248.35 |
April 29, 2024 | 2121.99 |
April 26, 2024 | 2111.36 |
April 25, 2024 | 2086.49 |
April 24, 2024 | 2107.59 |
April 23, 2024 | 2146.42 |
April 22, 2024 | 2105.09 |
April 19, 2024 | 2090.64 |
April 18, 2024 | 2147.17 |
April 17, 2024 | 2161.05 |
April 16, 2024 | 2149.45 |
April 15, 2024 | 2161.05 |
April 12, 2024 | 2163.55 |
April 11, 2024 | 2186.43 |
April 10, 2024 | 2193.31 |
April 09, 2024 | 2179.67 |
April 08, 2024 | 2237.38 |
April 05, 2024 | 2257.30 |
Date | Value |
---|---|
April 04, 2024 | 2210.87 |
April 03, 2024 | 2233.64 |
April 02, 2024 | 2199.01 |
April 01, 2024 | 2189.20 |
March 28, 2024 | 2239.31 |
March 27, 2024 | 2239.94 |
March 26, 2024 | 2230.50 |
March 25, 2024 | 2225.44 |
March 22, 2024 | 2218.15 |
March 21, 2024 | 2217.15 |
March 20, 2024 | 2224.63 |
March 19, 2024 | 2224.40 |
March 18, 2024 | 2195.27 |
March 15, 2024 | 2170.83 |
March 14, 2024 | 2189.72 |
March 13, 2024 | 2181.40 |
March 12, 2024 | 2173.08 |
March 11, 2024 | 2113.84 |
March 08, 2024 | 2193.77 |
March 07, 2024 | 2245.64 |
March 06, 2024 | 2244.52 |
March 05, 2024 | 2238.25 |
March 04, 2024 | 2280.53 |
March 01, 2024 | 2251.29 |
February 29, 2024 | 2169.42 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
286.15
Minimum
Jul 19 2019
2280.53
Maximum
Mar 04 2024
833.98
Average
696.37
Median
Nov 30 2021
Total Return Level Benchmarks
Amgen Inc | 434.89 |
Biogen Inc | 222.87 |
Madrigal Pharmaceuticals Inc | 207.15 |
Vertex Pharmaceuticals Inc | 418.99 |
Viking Therapeutics Inc | 80.22 |